Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Interest & Investment Income (2020 - 2024)

Historic Interest & Investment Income for Silence Therapeutics (SLN) over the last 5 years, with Q3 2024 value amounting to $1.3 million.

  • Silence Therapeutics' Interest & Investment Income fell 5081.82% to $1.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.7 million, marking a year-over-year decrease of 3496.29%. This contributed to the annual value of $1.8 million for FY2023, which is 1400.47% up from last year.
  • Per Silence Therapeutics' latest filing, its Interest & Investment Income stood at $1.3 million for Q3 2024, which was down 5081.82% from $1.3 million recorded in Q2 2024.
  • Silence Therapeutics' 5-year Interest & Investment Income high stood at $189.7 million for Q3 2020, and its period low was -$408411.2 during Q1 2023.
  • Moreover, its 5-year median value for Interest & Investment Income was $1.0 million (2024), whereas its average is $12.8 million.
  • In the last 5 years, Silence Therapeutics' Interest & Investment Income skyrocketed by 3190100.48% in 2022 and then plummeted by 18696.22% in 2023.
  • Over the past 5 years, Silence Therapeutics' Interest & Investment Income (Quarter) stood at $290499.2 in 2020, then plummeted by 91.65% to $24264.2 in 2021, then skyrocketed by 31901.0% to $7.8 million in 2022, then tumbled by 59.98% to $3.1 million in 2023, then plummeted by 58.99% to $1.3 million in 2024.
  • Its Interest & Investment Income stands at $1.3 million for Q3 2024, versus $1.3 million for Q2 2024 and $1.0 million for Q1 2024.